Analysed REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ) News Sources
Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma
24-07-2026
biopharmadive.com
Big pharma’s patent cliff meets a new biotech Cold War: We need to outrun China, not outlaw it
24-07-2026
yahoo.com
Can Revolution Medicines (RVMD) Justify Its Valuation On Daraxonrasib Survival Data?
25-07-2026
yahoo.com
Revolution Medicines (RVMD) Wins FDA Review Milestone For Daraxonrasib In Pancreatic Cancer
25-07-2026
yahoo.com
Revolution Medicines (RVMD) Stock Looks Fully Priced With Strong Returns But Weak Value Checks
25-07-2026
yahoo.com
Will FDA Priority Review for Daraxonrasib Redefine Revolution Medicines' (RVMD) Pancreatic Cancer Narrative?
25-07-2026
yahoo.com
Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026
29-07-2026
yahoo.com
What is the current price of REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ)?
The current price of REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ) is $9.565.
REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ) absolute price change since previous trading day?
The absolute price change of REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ) since the previous trading day is $-0.315.
REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ) percentage price change since previous trading day?
The percentage price change of REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ) since the previous trading day is -3.1883%.
What is the most recent average sentiment score for REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ)?
The most recent average sentiment score for REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ)?
The most recent sentiment for REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ) is .
SEC-8K** Filing Available For REVOLUTION MEDICINES INC-28 (RVMDW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.